<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the criteria of refractory cytopenia with multilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RCMD</z:e>) according to the WHO (World Health Organization) classification, the frequency threshold concerning <z:mpath ids='MPATH_589'>dysplasia</z:mpath> of each lineage was defined as 10% </plain></SENT>
<SENT sid="1" pm="."><plain>To predict overall survival (OS) and <z:hpo ids='HP_0001909'>leukemia</z:hpo>-free survival (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e>) for patients with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA) according to the French-American-British (FAB) classification, we investigated prognostic factors based on the morphological features of 100 Japanese and 87 German FAB-RA patients, excluding <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q-syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In the univariate analysis of <z:hpo ids='HP_0000001'>all</z:hpo> patients, pseudo-<z:e sem="disease" ids="C0865271" disease_type="Disease or Syndrome" abbrv="">Pelger-Huet anomalies</z:e> &gt;or=10% (Pelger+), micromegakaryocytes &gt;or=10% (mMgk+), dysgranulopoiesis (dys G) &gt;or=10% and dysmegakaryopoiesis (dys Mgk) &gt;or=40% were unfavorable prognostic factors for OS and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e> (OS; P&lt;0.001, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e>; P&lt;0.001) </plain></SENT>
<SENT sid="3" pm="."><plain>The prognostic effects of the morphological features were similar in both Japanese and German patients </plain></SENT>
<SENT sid="4" pm="."><plain>However, dys Mgk &gt;or=10% was not correlated with OS and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In the multivariate analysis, mMgk+ and dys Mgk&gt;or=40% were adverse prognostic factors for OS for <z:hpo ids='HP_0000001'>all</z:hpo> patients, and dys G &gt;or=10% and dys Mgk&gt;or=40% were adverse prognostic factors for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e> for <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="6" pm="."><plain>On the basis of the present analysis, we propose the following modified morphological criteria for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RCMD</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Modified <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RCMD</z:e> should be defined as FAB-RA, excluding <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q-syndrome</z:e> with dys G &gt;or=10%, dys Mgk&gt;or=40% or mMgk+ </plain></SENT>
</text></document>